Kang, W K <br/><br/>
Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study.  [electronic resource] 

 -  Human gene therapy  Apr 2001 
 - 671-84 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1043-0342 
<br/><br/><label>Standard No.: </label>10.1089/104303401300057388  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>CD8-Positive T-Lymphocytes--immunology<br/>Female<br/>Fibroblasts--metabolism<br/>Gene Transfer Techniques<br/>Genetic Therapy--methods<br/>Humans<br/>Immunoenzyme Techniques<br/>Interleukin-12--genetics<br/>Killer Cells, Natural--immunology<br/>Male<br/>Melanoma--immunology<br/>Middle Aged<br/>Retroviridae--genetics<br/>Skin Neoplasms--immunology<br/>T-Lymphocytes--immunology<br/>Transforming Growth Factor beta--metabolism<br/>Tumor Cells, Cultured<br/>Tumor Necrosis Factor-alpha--metabolism